Sectors
NRXP
NRx Pharmaceuticals, Inc.
3.46
1 x 3.43
1 x 3.44
bid
ask
+
0.11
3.28%
09:40 AM
timesize
| Ytd | 27.68% | |
| 1y | 49.14% |
3.38
day range
3.47
1.62
52 week range
5.05
| Open | 3.39 | Prev Close | 3.35 | Low | 3.38 | High | 3.47 | Mkt Cap | 59.81M |
| Vol | 103.91K | Avg Vol | 1.28M | EPS | -0.37 | P/E | -9.35 | Forward P/E | -1.12 |
| Beta | 2.18 | Short Ratio | 4.80 | Inst. Own | 6.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 3.89 | 200-d Avg | 2.78 | 1yr Est | 31.67 |
| Income Statement | |||
| Total Revenue | 1.07M | ||
| Revenues (USD) | 1.07M | ||
| Cost of Revenue | 631.00K | ||
| Gross Profit | 437.00K | ||
| Operating Expenses | 5.18M | ||
| Research and Development Expense | 1.31M | ||
| Selling, General and Administrative Expense | 3.81M | ||
| Operating Income | -4.74M | ||
| Interest Expense | 233.00K | ||
| Net Income | -1.43M | ||
| Net Income Common Stock | -1.43M | ||
| Net Income Common Stock (USD) | -1.43M | ||
| Consolidated Income | -1.43M | ||
| Earnings per Basic Share | -0.04 | ||
| Earnings per Basic Share (USD) | -0.04 | ||
| Earnings per Diluted Share | -0.04 | ||
| Earning Before Interest & Taxes (EBIT) | -1.20M | ||
| Earning Before Interest & Taxes (USD) | -1.20M | ||
| Weighted Average Shares | 32.33M | ||
| Weighted Average Shares Diluted | 32.33M | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.71M | ||
| Cash and Equivalents (USD) | 6.71M | ||
| Investments | 399.00K | ||
| Investments Non-Current | 399.00K | ||
| Trade and Non-Trade Receivables | 181.00K | ||
| Current Assets | 7.36M | ||
| Property, Plant & Equipment Net | 1.20M | ||
| Total Assets | 11.90M | ||
| Debt Current | 391.00K | ||
| Total Debt | 934.00K | ||
| Current Liabilities | 25.18M | ||
| Debt Non-Current | 543.00K | ||
| Total Liabilities | 25.72M | ||
| Accumulated Retained Earnings (Deficit) | -308.32M | ||
| Shareholders Equity | -13.82M | ||
| Shareholders Equity (USD) | -13.82M | ||
| Assets Non-Current | 4.54M | ||
| Total Debt (USD) | 934.00K | ||
| Goodwill and Intangible Assets | 2.67M | ||
| Liabilities Non-Current | 543.00K | ||
| Trade and Non-Trade Payables | 4.40M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 165.00K | ||
| Net Cash Flow from Financing | 3.42M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.08M | ||
| Issuance (Purchase) of Equity Shares | 3.42M | ||
| Net Cash Flow from Investing | -213.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -213.00K | ||
| Net Cash Flow from Operations | -4.29M | ||
| Share Based Compensation | 151.00K | ||